Partnerships For Success Opioid Misuse and Heroin Use Prevention

The State of Alaska's Department of Health and Social Services, Division of Behavioral Health(DBH) issued the Strategic Prevention Framework Partnerships for Success Grant (SPF PFS) to coalitions across the state of Alaska to prevent the non-medical use of prescription opioids(NMUPO) among 12-25 year olds and heroin use among 18-25 year olds. Within Anchorage, the Volunteers of America Alaska's Healthy Voices Healthy Choices coalition (HVHC) was awarded funding. HVHC contracted with Alaska Injury Prevention Center (AIPC) to conduct this assessment.


Purpose of Assessment

The DBH tasked grantees with collecting data pertaining to NMUPO among 12-25 year olds and heroin use among 18-25 years old. Through the assessment, grantees were to collect data pertaining to the nature of NMUPO and heroin use and related consequences, including health disparities related to NMUPO and heroin use. Grantees were also asked to assess intervening and community factors. Specifically, grantees were required to assess community factors related to social and retail availability, and perceived risk for harm of NMUPO and heroin use, and an additional intervening variable the coalition identified in this process is regarding harm reduction. PFS grantees were additionally asked to assess the community's capacity and readiness to address NMUPO and heroin use.


For more information please contact:
Charlie Daniels
Vice President of Prevention and Intervention
(907) 265-1912



Image_001.png

Mortality Rate

Data collected from the Alaska Bureau of Vital Statistics mortality database, shows that from 2009-2015, there were 774 drug overdose deaths. 400 of these deaths were from opioid pain relievers and 128 were heroin related. Of the 311the number of accidental poisoning deaths doubled from 66 in 2005 to 133 in 2012 (Strayer, Craig, Asay, Haakenson, & Provost, 2014). Poisoning deaths include, but are not limited to, unintentional overdoses from drugs. The number of heroin overdose deaths in Alaska increased by a factor of four from 2008-2013 (Hull-Jilly, Frasene, Gebru, & Boegli, 2015).